Wed, 03 Jun 2009 15:02:57 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/endocrinology/podcast_endoCME-CNE-CPE_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Endocrinology no PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, an expert in diabetes discusses optimal management strategies in a diabetic patient who has been failing standard therapy and in a treatment-naïve diabetic patient with renal impairment. Other specific challenges, such as minimizing the risk of hypoglycemia, are also explored. http://podcast.peerviewpress.com/endocrinology/PA05738FCp156.mp3 http://podcast.peerviewpress.com/endocrinology/PA05738FCp156.mp3 Thu, 21 May 2009 14:52:25 -0400 Science, Medicine no 00:36:30 diabetes, glycemic control, A1C, incretin PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/endocrinology/PA05738FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA05738FCCMEinfo.pdf Thu, 21 May 2009 14:52:23 -0400 Science, Medicine no 00:00:00 diabetes, glycemic control, A1C, incretin PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in the management of HIV discuss the clinical implications of the latest updates to the DHHS guidelines. http://podcast.peerviewpress.com/endocrinology/PA05393FCr439.mp3 http://podcast.peerviewpress.com/endocrinology/PA05393FCr439.mp3 Tue, 21 Apr 2009 15:19:41 -0400 Science, Medicine no 00:26:28 HIV; DHHS guidelines; HIV guidelines; ART; antiretroviral therapy PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/endocrinology/PA05393FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA05393FCCMEinfo.pdf Tue, 21 Apr 2009 15:19:39 -0400 Science, Medicine no 00:00:00 HIV; DHHS guidelines; HIV guidelines; ART; antiretroviral therapy PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in the management of type 2 diabetes discuss the role of postprandial hyperglycaemia in achieving optimal glycaemic control and reducing the risk of cardiovascular events. http://podcast.peerviewpress.com/endocrinology/PI04742FCe025.mp3 http://podcast.peerviewpress.com/endocrinology/PI04742FCe025.mp3 Thu, 16 Apr 2009 15:42:12 -0400 Science, Medicine no 00:45:31 type 2 diabetes, hyperglycaemia, hypoglycaemia, postprandial glucose, glycaemic control, monitoring, cardiovascular disease PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/endocrinology/PI04742FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PI04742FCCMEinfo.pdf Thu, 16 Apr 2009 15:42:10 -0400 Science, Medicine no 00:00:00 type 2 diabetes, hyperglycaemia, hypoglycaemia, postprandial glucose, glycaemic control, monitoring, cardiovascular disease PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, two leading experts in the area of HIV management will analyze the latest treatment guidelines for managing metabolic and cardiovascular risk in patients with HIV. Topics in these discussions include cardiovascular and metabolic considerations for individualizing therapy, treatment selection, and insight regarding switching therapies. In addition, practical considerations for the screening, monitoring, and management of these comorbidities in patients with HIV will be discussed. http://podcast.peerviewpress.com/Endocrinology/PA04256FCr431.mp3 http://podcast.peerviewpress.com/endocrinology/PA04256FCr431.mp3 Tue, 24 Mar 2009 14:42:21 -0400 Science, Medicine no 00:30:41 HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA04256FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA04256FCCMEinfo.pdf Tue, 24 Mar 2009 14:42:18 -0400 Science, Medicine no 00:00:00 HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, an expert in painful DPN discusses differential diagnosis of the condition and management approaches in treatment-naïve patients as well as in individuals with established diagnosis. http://podcast.peerviewpress.com/Endocrinology/PA05052FCp151.mp3 http://podcast.peerviewpress.com/endocrinology/PA05052FCp151.mp3 Mon, 09 Mar 2009 14:03:52 -0400 Science, Medicine no 00:27:39 diabetic peripheral neuropathy, DPN, diabetes, neuropathic pain, nerve damage, pregabalin, duloxetine, diagnosis PeerView Press Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA05052FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA05052FCCMEinfo.pdf Mon, 09 Mar 2009 14:03:48 -0400 Science, Medicine no 00:00:00 diabetic peripheral neuropathy, DPN, diabetes, neuropathic pain, nerve damage, pregabalin, duloxetine, diagnosis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in the management of type 2 diabetes discuss aspects of novel glucose-lowering therapies in the overall context of optimal disease management. http://podcast.peerviewpress.com/Endocrinology/PI04741FCr444.mp3 http://podcast.peerviewpress.com/endocrinology/PI04741FCr444.mp3 Thu, 26 Feb 2009 16:38:45 -0500 Science, Medicine no 00:47:37 diabetes, DPP-4, incretin, hypoglycaemia, A1C, ACCORD, ADVANCE, metformin, EASD, ADA, saxagliptin, sitagliptin PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://podcast.peerviewpress.com/Endocrinology/PI04741FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PI04741FCCMEinfo.pdf Thu, 26 Feb 2009 16:38:43 -0500 Science, Medicine no 00:00:00 diabetes, DPP-4, incretin, hypoglycaemia, A1C, ACCORD, ADVANCE, metformin, EASD, ADA, saxagliptin, sitagliptin PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured. http://podcast.peerviewpress.com/Endocrinology/PA04255FCr403.mp3 http://podcast.peerviewpress.com/endocrinology/PA04255FCr403.mp3 Tue, 25 Nov 2008 15:15:55 -0500 Science no 00:24:39 HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA04255FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA04255FCCMEinfo.pdf Thu, 31 Jul 2008 15:15:54 -0400 Science no 00:00:00 HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this activity, experts in the treatment of diabetes explore the use of incretin-based therapies in the management of this condition. An assessment of data from the 68th Scientific Sessions of the American Diabetes Association is featured. http://podcast.peerviewpress.com/Endocrinology/PA04206FCe020.mp3 http://podcast.peerviewpress.com/endocrinology/PA04206FCe020.mp3 Mon, 14 Jul 2008 15:27:46 -0400 Science no 00:33:35 diabetes, incretin, beta-cell, DPP-IV inhibitors, GLP-1, GIP, sitagliptin, exenatide, liraglutide, alogliptin PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA04206FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA04206FCCMEinfo.pdf Mon, 14 Jul 2008 15:27:45 -0400 Science no 00:00:00 diabetes, incretin, beta-cell, DPP-IV inhibitors, GLP-1, GIP, sitagliptin, exenatide, liraglutide, alogliptin PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this activity, an expert in the treatment of diabetes investigates the importance of addressing the many cardiometabolic risk factors that are present in patients with type 2 diabetes. The activity also features an analysis of the impact of newer antidiabetic agents, including incretin mimetics and DPP-IV inhibitors, on improving a number of these risk factors. http://podcast.peerviewpress.com/Endocrinology/PA04817FCn186.mp3 http://podcast.peerviewpress.com/endocrinology/PA04817FCn186.mp3 Wed, 02 Jul 2008 14:02:06 -0400 Science no 00:24:31 Diabetes, exenatide, sitagliptin, 68th Scientific Sessions of the American Diabetes Association, GLP-1 receptor agonists, DPP-IV inhibitors, obesity, cardiovascular disease PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA04817FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA04817FCCMEinfo.pdf Wed, 02 Jul 2008 14:02:04 -0400 Science no 00:00:00 Diabetes, exenatide, sitagliptin, 68th Scientific Sessions of the American Diabetes Association, GLP-1 receptor agonists, DPP-IV inhibitors, obesity, cardiovascular disease PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME activity, an expert in the treatment of male hypogonadism discusses the diagnosis and treatment of this condition. Testosterone replacement therapy and the different treatment modalities are also reviewed. http://podcast.peerviewpress.com/Endocrinology/PA03527FCp117.mp3 http://podcast.peerviewpress.com/endocrinology/PA03527FCp117.mp3 Wed, 05 Sep 2007 16:13:42 -0400 Science no 00:32:09 Male hypogonadism, testosterone, testosterone replacement therapy, TRT, delivery systems, transdermal patches, buccal system, testosterone gel, intramuscular injections, subcutaneous pellets, metabolic syndrome PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03537FCp117.pdf http://podcast.peerviewpress.com/endocrinology/PA03527FCCMEinfo.pdf Wed, 05 Sep 2007 16:12:42 -0400 Science no 00:00:00 Male hypogonadism, testosterone, testosterone replacement therapy, TRT, delivery systems, transdermal patches, buccal system, testosterone gel, intramuscular injections, subcutaneous pellets, metabolic syndrome PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME activity, an expert in the management of type 2 diabetes discusses recent data on current and emerging glucagon-like peptide (GLP-1) mimetics and dipeptidyl peptidase IV (DPP-IV) inhibitors. http://podcast.peerviewpress.com/Endocrinology/PA03868FCn166.mp3 http://podcast.peerviewpress.com/endocrinology/PA03868FCn166_2.mp3 Fri, 03 Aug 2007 16:17:47 -0400 Science no 00:19:40 Diabetes, T2DM, insulin resistance, glucagon-like peptide-1, GLP-1, DPP-IV inhibitors, sulfonylureas, meglitinides, metformin, thiazolidinediones, insulin, exenatide, liraglutide, sitagliptin, vildagliptin, alogliptin, SYR-322, BI 1356, ABT-279 PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03868FCn166.pdf http://podcast.peerviewpress.com/endocrinology/PA03868FCn166.pdf Fri, 03 Aug 2007 16:17:41 -0400 Science no 00:00:00 Diabetes, T2DM, insulin resistance, glucagon-like peptide-1, GLP-1, DPP-IV inhibitors, sulfonylureas, meglitinides, metformin, thiazolidinediones, insulin, exenatide, liraglutide, sitagliptin, vildagliptin, alogliptin, SYR-322, BI 1356, ABT-279 PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME activity, experts in the treatment of diabetes present recent data on the efficacy and safety of therapies used in the management of this disease. Recent data on the pathophysiology of the development of diabetes will be addressed. http://podcast.peerviewpress.com/Endocrinology/PA03836FCr313.mp3 http://podcast.peerviewpress.com/endocrinology/PA03836FCr313.mp3 Tue, 26 Jun 2007 15:45:04 -0400 Science no 00:29:24 Diabetes, T2DM, insulin resistance, glucagon-like peptide-1, GLP-1, DPP-IV inhibitors, sulfonylureas, meglitinides, metformin, carbohydrate absorption inhibitors, thiazolidinediones, insulin, pramlintide, exenatide, liraglutide, ZP10, sitagliptin PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03836FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA03836FCCMEinfo.pdf Tue, 26 Jun 2007 15:44:31 -0400 Science no 00:00:00 Diabetes, T2DM, insulin resistance, glucagon-like peptide-1, GLP-1, DPP-IV inhibitors, sulfonylureas, meglitinides, metformin, carbohydrate absorption inhibitors, thiazolidinediones, insulin, pramlintide, exenatide, liraglutide, ZP10, sitagliptin PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file or full CME/CE information. In this CME/CE activity, experts in the management of diabetes and cardiovascular disease discuss recent data on the management of cardiovascular risk in people with type 2 diabetes. New insights on the etiology and diagnosis of cardiovascular disease in this population are reviewed. The current guidelines for management of CV events are highlighted. http://podcast.peerviewpress.com/Endocrinology/PA03563FCr259.mp3 http://podcast.peerviewpress.com/endocrinology/PA03563FCr259.mp3 Thu, 08 Mar 2007 16:29:54 -0500 Science no 00:33:00 diabetes, type 2 diabetes, cardiovascular disease, cardiovascular risk, lipids, glucose, metabolic syndrome, A1C, intima-media thickness, thiazolidinediones, pioglitazone, rosiglitazone, glimepiride, metformin, TZDs, glyburide, DREAM trial, CHICAGO trial PVI, PeerView Institute for Medical Education Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/Endocrinology/PA03563FCCMEinfo.pdf http://podcast.peerviewpress.com/endocrinology/PA03563FCCMEinfo.pdf Thu, 08 Mar 2007 16:29:44 -0500 Science no 00:00:00 diabetes, type 2 diabetes, cardiovascular disease, cardiovascular risk, lipids, glucose, metabolic syndrome, A1C, intima-media thickness, thiazolidinediones, pioglitazone, rosiglitazone, glimepiride, metformin, TZDs, glyburide, DREAM trial, CHICAGO trial